AGP Executive Report
Last update: 4 hours agoMedicine Supply & Shortages: A UK pharmacist says the NHS medicine shortage is the worst in his career, with supply problems hitting painkillers, epilepsy treatments, HRT and even statins—costs and access are both getting worse. Drug Safety & Regulation: India has banned 16 fixed-dose combination drugs after a review found weak medical justification and higher risk than benefit. Medicare Access: CMS is rolling out a temporary “GLP-1 Bridge” for some Medicare Part D users starting July 1, 2026, with a flat $50 monthly copay aimed mainly at weight management. Fraud & Enforcement: US authorities arrested a fugitive tied to a $1.2B Medicare fraud scheme in the Philippines, while California prosecutors continue to target hospice billing fraud. Healthcare Integrity: Malaysia is considering digital medical certificates after cases of forged certificates and stolen doctor identities. Pharma Business Moves: Sun Pharma agreed to buy Innovcare Lifesciences for ₹271 crore to expand nutraceuticals. Public Health & Access: Paraguay and the US launched the third Amistad medical mission, delivering free care through local health units. Workforce & Education: Philippines regulators approved new Doctor of Medicine programs in five state universities. Conflict & Care: Israeli strikes in Gaza killed at least nine people, including a child and a journalist, according to medics.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.